Hvsen Biotechnology Co., Ltd.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 258 400 422 427 777 996 1,023 1,020 1,200
Przychód Δ r/r 0.0% 55.1% 5.5% 1.3% 82.0% 28.1% 2.7% -0.3% 17.7%
Marża brutto 52.7% 50.7% 43.6% 38.3% 37.0% 27.2% 22.0% 20.6% 16.3%
EBIT (mln) 55 103 81 79 177 151 59 15 -29
EBIT Δ r/r 0.0% 89.6% -21.2% -3.6% 124.7% -14.4% -60.8% -74.5% -292.8%
EBIT (%) 21.1% 25.9% 19.3% 18.4% 22.7% 15.2% 5.8% 1.5% -2.4%
Koszty finansowe (mln) 0 1 4 5 2 3 18 28 43
EBITDA (mln) 64 117 112 104 203 175 149 161 127
EBITDA(%) 24.8% 29.4% 26.6% 24.2% 26.1% 17.5% 14.6% 15.8% 10.6%
Podatek (mln) 9 15 10 10 26 18 4 -4 -9
Zysk Netto (mln) 49 88 71 69 150 133 53 17 -20
Zysk netto Δ r/r 0.0% 78.9% -19.3% -3.7% 118.4% -11.5% -60.3% -68.2% -220.1%
Zysk netto (%) 19.2% 22.1% 16.9% 16.1% 19.3% 13.3% 5.2% 1.6% -1.7%
EPS 0.41 0.74 0.59 0.41 0.91 0.8 0.32 0.1 -0.12
EPS (rozwodnione) 0.41 0.74 0.59 0.41 0.91 0.8 0.32 0.1 -0.12
Ilośc akcji (mln) 0 119 120 166 166 166 165 166 166
Ważona ilośc akcji (mln) 0 119 120 166 166 166 165 166 166
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY